Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
WHO Declares Coronavirus Outbreak A Global Health Emergency
The World Health Organization announced Thursday that the outbreak of a deadly and fast-spreading strain of coronavirus constitutes a global health emergency.
New drug candidate created by AI in ‘world first’
Exscientia and and Japanese company Sumitomo Dainippon have announced that a joint AI-developed drug has been initiated for the treatment of obsessive-compulsive disorder as an initial indication.
Nanoparticle helps eat away deadly arterial plaque
As many readers will already know, atherosclerotic plaque-deposits on the inner walls of arteries are a frequent cause of heart attacks and strokes.
Acceleron's pulmonary hypertension treatment meets main goal, shares soar 79%
(Reuters) - Acceleron Pharma Inc (XLRN.
WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus
SHANGHAI, China, January 29, 2020–WuXi Biologics (“WuXi Bio”) (2269.
FDA faults Biocon small molecule API facility during preapproval review
The FDA has found a handful of issues with Biocon’s small molecule API facility in Bengaluru, India.
Quality of life extended with atezolizumab and bevacizumab in liver cancer
(HealthDay)—For patients with unresectable hepatocellular carcinoma, the combination of atezolizumab and bevacizumab is associated with longer time to deterioration of patient-reported quali...
Johnson & Johnson ‘pretty confident’ it can develop coronavirus vaccine
Drugmaker Johnson & Johnson is “pretty confident” that it can create a vaccine to combat the deadly coronavirus, an exec said Monday.
FDA Approves Trijardy XR for Type 2 Diabetes in Adults
The U.
Novel molecules display potent and selective action against ovarian tumor cells
A group led by a researcher affiliated with the University of São Paulo's São Carlos Chemistry Institute (IQSC-USP) in Brazil has developed a novel palladium compound that acts against o...
China's coronavirus: rising death toll, global impact
A new virus that China announced in late December has killed more than 100 people, infected more than 4,000 and spread to around 15 countries.
Brilinta hits endpoint in late-stage stroke trial
AstraZeneca has revealed results from its Brilinta (ticagrelor) trial, demonstrating that the drug showed a statistically significant and clinically meaningful reduction in the risk of stroke ...
328
329
330
331
332
333
334
335
336
